London · Delayed Price · Currency is GBP · Price in USD ACADIA Pharmaceuticals Statistics
Total Valuation
LON:0A4W has a market cap or net worth of GBP 2.89 billion. The enterprise value is 2.27 billion.
| Market Cap | 2.89B |
| Enterprise Value | 2.27B |
Important Dates
The last earnings date was Wednesday, November 5, 2025.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 166.39M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.70% |
| Shares Change (QoQ) | +1.17% |
| Owned by Insiders (%) | 0.53% |
| Owned by Institutions (%) | 70.27% |
| Float | 115.87M |
Valuation Ratios
The trailing PE ratio is 14.87 and the forward PE ratio is 54.72.
| PE Ratio | 14.87 |
| Forward PE | 54.72 |
| PS Ratio | 3.71 |
| PB Ratio | 4.23 |
| P/TBV Ratio | 4.82 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 11.70 |
| EV / Sales | 2.83 |
| EV / EBITDA | 24.45 |
| EV / EBIT | 31.39 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.02, with a Debt / Equity ratio of 0.05.
| Current Ratio | 3.02 |
| Quick Ratio | 2.77 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.35 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 34.95% and return on invested capital (ROIC) is 7.44%.
| Return on Equity (ROE) | 34.95% |
| Return on Assets (ROA) | 5.11% |
| Return on Invested Capital (ROIC) | 7.44% |
| Return on Capital Employed (ROCE) | 9.69% |
| Revenue Per Employee | 1.19M |
| Profits Per Employee | 297,091 |
| Employee Count | 654 |
| Asset Turnover | 0.91 |
| Inventory Turnover | 8.61 |
Taxes
In the past 12 months, LON:0A4W has paid 9.30 million in taxes.
| Income Tax | 9.30M |
| Effective Tax Rate | 4.57% |
Stock Price Statistics
The stock price has decreased by -31.17% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -31.17% |
| 50-Day Moving Average | 17.41 |
| 200-Day Moving Average | 16.42 |
| Relative Strength Index (RSI) | 58.25 |
| Average Volume (20 Days) | 2,167 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LON:0A4W had revenue of GBP 778.99 million and earned 194.30 million in profits. Earnings per share was 1.15.
| Revenue | 778.99M |
| Gross Profit | 490.47M |
| Operating Income | 70.23M |
| Pretax Income | 203.59M |
| Net Income | 194.30M |
| EBITDA | 80.66M |
| EBIT | 70.23M |
| Earnings Per Share (EPS) | 1.15 |
Balance Sheet
The company has 630.13 million in cash and 32.01 million in debt, giving a net cash position of 598.12 million.
| Cash & Cash Equivalents | 630.13M |
| Total Debt | 32.01M |
| Net Cash | 598.12M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 682.40M |
| Book Value Per Share | 4.04 |
| Working Capital | 535.52M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 62.96%, with operating and profit margins of 9.02% and 24.94%.
| Gross Margin | 62.96% |
| Operating Margin | 9.02% |
| Pretax Margin | 26.14% |
| Profit Margin | 24.94% |
| EBITDA Margin | 10.35% |
| EBIT Margin | 9.02% |
| FCF Margin | n/a |
Dividends & Yields
LON:0A4W does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.70% |
| Shareholder Yield | -1.70% |
| Earnings Yield | 6.73% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |